Hong-Cheol Kim

Samsung Venture Investment Corp. (SVIC) is a corporate venture capital investment firm based in Seoul, South Korea. Founded in 1999, they manage investment and investment-related activities for the Samsung Group. The parent firm, founded in 1938 and headquartered in Seoul, produces semiconductors, business communications systems, reciprocating and rotary compressors, optical and hard disc drives, LCD panels, set-top boxes, CC televisions, as well as fiber optics. In 2004, SVIC established Samsung Ventures America, their US-based venture capital arm.

Daewoong Bio, Inc. provides pharmaceutical raw materials and intermediate products. Its products include acids, anti-hyperlipidaemic agents, tranquilisers, antiulcerants, antifungals, dietary supplements, anti-thrombotics, cephalosporins, anti-hypertensives, hepatic protectors, penicillin, digestives, diphenyl dimethyl bicarboxylate, amoxicillin, and alibendol. The company was founded on April 15, 1983 and is headquartered in Hwaseong, South Korea.

Kyung Hee University provides academic courses and grants academic degrees. It has udergraduate, graduate, international student, and international faculty programs. The firm also provides scholarships and operates Kyung Hee Medical Center, Kyung Hee University Hospital at Gangdong, and Kangnam Korean Hospital. The company was founded on February 15, 1949 and is headquartered in Seoul, South Korea.

Part of Daewoong Co., Ltd., Healience Co., Ltd. is a South Korean company that provides tourist accommodation. The company is based in Hongcheon, South Korea and was founded in 2005.

Part of Daewoong Co., Ltd., Ezmedicom Co. Ltd. is a medical e-commerce leader that leads the way in medical e-business. The South Korean company promises a win-win for purchasing hospitals, suppliers, and investors as a future-oriented company. The text is in Korean and has been translated to English.